Date	Period	Revenue/Estimate	Earnings Call
--	2025/FY	-- / 1.378B	--
--	2024/FY	-- / 1.095B	--
Mar 24, 2022	2021/FY	76.325M / 51.900M	--
Mar 23, 2021	2020/FY	22.491M / 53.213M	--
Mar 17, 2020	2019/FY	45.308M / 58.000M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/FY-- / 1.378B--

--2024/FY-- / 1.095B--

Mar 24, 20222021/FY76.325M / 51.900M--

Mar 23, 20212020/FY22.491M / 53.213M--

Mar 17, 20202019/FY45.308M / 58.000M--

Unlock Free Earnings Estimates

Open Account

TOT BIOPHARM-B: INTERIM REPORT 2024

Sep 25 05:58 ET

TOT BIOPHARM-B: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2024

Aug 13 09:58 ET

TOT BIOPHARM-B: DATE OF BOARD MEETING

Aug 1 04:34 ET

TOT BIOPHARM-B: ANNUAL REPORT 2023

Apr 26 06:01 ET

Overall

No Data